Regardless of the sequential decrease in Current Liabilities, during the third quarter 2026, Quick Ratio deteriorated to 0.01 a new company low.

Within Major Pharmaceutical Preparations industry 656 other companies have achieved higher Quick Ratio than Chemocentryx in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 1040 to 6221.

Explain Quick Ratio?
How much Cash & cash equivalents CCXI�s has?
What are CCXI�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CCXI/financial-strength

https://api.csimarket.com/api/v1/companies/CCXI/fundamentals

https://api.csimarket.com/api/v1/companies/CCXI/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

CCXI Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q3	(Jun 30 2022) Q2
Y / Y Current Liabilities Change	-59.39 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-99.94 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	0.01	Subscribe	Subscribe	Subscribe	Subscribe
CCXI's Total Ranking	# 6221	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	-77.91 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	-83.59 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 657
Healthcare Sector	# 1310
Overall Market	# 6221

Quick Ratio Statistics
High	Average	Low
26.59	8.12	0.01
(Dec 31 2015)		(Jun 30 2026)

Financial Statements
Chemocentryx's Current Liabilities	$ 31 Millions	Visit CCXI's Balance sheet
Chemocentryx's Cash & cash equivalent	$ 0 Millions	Visit CCXI's Balance sheet
Source of CCXI's Sales		Visit CCXI's Sales by Geography

Cumulative Chemocentryx's Quick Ratio

CCXI's Quick Ratio for the trailling 12 Months

CCXI Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Jun 30 2022) 12 Months
Y / Y Current Liabilities TTM Growth	-36.22 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-99.78 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	0.02	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 5364	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	-20.91 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-99.21 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to CCXI Financial Strength Comparisons >> Go to Compare CCXI Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in CCXI's Current Liabilities to $30.89 millions, cumulative Quick Ratio to 0.02 below the CCXI average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 590 other companies have achieved higher Quick Ratio than Chemocentryx. While Quick Ratio overall ranking has improved so far to 5364, from total ranking during the twelve months ending second quarter 2026 at 5448.

Explain Quick Ratio?
How much Cash & cash equivalents CCXI�s has?
What are CCXI�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 591
Healthcare Sector	# 1184
Within the Market	# 5364

trailing twelve months Quick Ratio Statistics
High	Average	Low
3.24	1.45	0.41
(Mar 31 2014)		(Sep 30 2017)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Major Pharmaceutical Preparations Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Artelo Biosciences Inc	0.01	$ 0.004 Millions	$ 0.439 Millions
IMPACT BIOMEDICAL INC.	0.01	$ 0.021 Millions	$ 2.373 Millions
Chemocentryx Inc.	0.01	$ 0.206 Millions	$ 30.892 Millions
Semnur Pharmaceuticals Inc	0.00	$ 0.054 Millions	$ 11.279 Millions
Evofem Biosciences Inc	0.00	$ 0.126 Millions	$ 84.776 Millions

Date modified: 2026-11-14T07:54:22+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.